Type | Total adverse drug events (n = 815) N (percent) | Preventable adverse drug events (n = 338) N (percent) |
Neuropsychiatric | 199 (24) | 97 (29) |
Hemorrhagic | 159 (20) | 53 (16) |
Gastrointestinal | 140 (17) | 55 (16) |
Renal/electrolytes | 80 (10) | 40 (12) |
Metabolic/endocrine | 64 (8) | 35 (10) |
Cardiovascular | 36 (4) | 15 (4) |
Dermatologic | 36 (4) | 4 (1) |
Extrapyramidal symptoms | 30 (4) | 7 (2) |
Fall with injury | 21 (3) | 17 (5) |
Fall without injury | 21 (3) | 11 (3) |
Infection | 19 (2) | 1 (<1) |
Syncope/dizziness | 16 (2) | 8 (2) |
Anticholinergic | 9 (1) | 3 (1) |
Ataxia/difficulty with gait | 9 (1) | 5 (2) |
Hematologic | 8 (1) | 3 (1) |
Respiratory | 6 (1) | 4 (1) |
Anorexia | 3 (<1) | 2 (<1) |
Functional decline | 3 (<1) | 2 (<1) |
Hepatic | 1 (<1) | 1 (<1) |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟